The Lowdown
Documentaries are not supposed to do this. A long, odd, ticketed nonfiction film about a convicted tech founder outperforming several studio releases on a fraction of the screens says Fielder’s audience will follow him anywhere. It also gives theaters a reason to stop treating docs as streaming filler.
Key Takeaways
- You Can See Everything opened at No. 2 for October 16–18 with $15.6 million from 855 theaters (Box Office Mojo).
- Its per-theater average was about $18,200, and pre-release forecasts had pointed to around $8 million (Enstarz).
- The film, directed by Nathan Fielder and Lance Oppenheim, follows Elizabeth Holmes in the weeks before she reported to prison (Enstarz).
- It premiered as Telluride’s mystery slot in September, and A24 set a wider expansion for October 23 (Enstarz).
The Story
The surprise of the October 16–18 weekend was a documentary. A24’s You Can See Everything opened at No. 2 with $15.6 million from just 855 theaters, behind only Street Fighter (Box Office Mojo).
That works out to roughly $18,200 per theater. Pre-release forecasts had placed the opening around $8 million, so the film came in at nearly double that estimate on less than a quarter of the screens of the weekend’s other wide releases (Enstarz).
Directed by Nathan Fielder and Lance Oppenheim, the nearly three-hour film follows Theranos founder Elizabeth Holmes in the weeks before she reported to federal prison. It premiered as the mystery slot at the Telluride Film Festival and held a 100% Rotten Tomatoes score at release (Enstarz).
It also outgrossed two new studio releases: 20th Century Studios’ Whalefall opened fourth with $7.8 million, and Focus Features’ Sense and Sensibility took fifth with $7.2 million. A24 announced it would widen the release on October 23 (Enstarz).
Latest News
Related
Join the Conversation
Coming soon.